![Olivier Bogillot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Bogillot
Director/Board Member at
CLARIANE SE
Net worth: 28 806 $ as of 31/05/2026
Profile
Olivier Bogillot is currently Chairman at Sanofi Pasteur Merieux SAS since 2020 and Independent Director at Clariane SE starting in 2025.
Former roles include Chairman & Chief Executive Officer at Sanofi-Aventis France SA and President & Director at Provention Bio, Inc. Education includes a doctorate from the University of Lyon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 5,897 ( 0% ) | 28 806 $ | 31/05/2026 |
Olivier Bogillot active positions
| Companies | Position | Start |
|---|---|---|
| CLARIANE SE | Director/Board Member | 14/05/2025 |
Sanofi Pasteur Merieux SAS
 Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Chairman | 01/03/2020 |
Former positions of Olivier Bogillot
| Companies | Position | End |
|---|---|---|
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Chief Executive Officer | - |
| PROVENTION BIO, INC. | President | - |
Training of Olivier Bogillot
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Clariane SE
 Clariane SE Medical/Nursing ServicesHealth Services Operates retirement homes | Health Services |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Finance |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- Olivier Bogillot
Choose MarketScreener 
